Targeted Drug Delivery Systems Using Magnetic Iron Oxide Nanocarriers for Cancer Therapy
DOI:
https://doi.org/10.55923/clarity.v5i1.2Abstract
Systemic chemotherapy toxicity remains a primary cause of therapeutic failure in oncology. Engineering folate-conjugated superparamagnetic iron oxide nanoparticles delivering doxorubicin under an external magnetic guidance field, this preclinical investigation proves selective tumor accumulation and significantly reduced cardiotoxic side effects.Downloads
Download data is not available.
Galleys
Published
2026-03-15
Issue
Section
Articles
How to Cite
Targeted Drug Delivery Systems Using Magnetic Iron Oxide Nanocarriers for Cancer Therapy. (2026). Clarity Research Journal, 5(1), 301-315. https://doi.org/10.55923/clarity.v5i1.2







